Stay updated on PRIMMO Clinical Trial
Sign up to get notified when there's something new on the PRIMMO Clinical Trial page.

Latest updates to the PRIMMO Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page has been updated to include a new version of the study on Pembrolizumab and related treatments, reflecting the latest findings, while the previous version has been removed.SummaryDifference0.6%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed descriptions of a Phase II study involving various cancer treatments and the addition of new collaborators and drug information. Notably, the principal investigator's name has been removed, and the revision number has been updated.SummaryDifference20%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe study on Pembrolizumab and a five-drug cocktail for cervical or endometrial carcinoma has been updated with a new erratum and revision, indicating a significant revision from v2.14.1 to v2.14.2.SummaryDifference0.6%
Stay in the know with updates to PRIMMO Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PRIMMO Clinical Trial page.